Newsroom

SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Veristat™, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced the launch of InStat™ by Veristat. InStat is the clinical research industry’s first zero-code, fully automated biostatistics solution, reducing manual effort to speed time to approval with every output backed by validated statistical engines and expert biostatistician review. It delivers submission-ready tables, listings, and figures (TLF) in...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 12.05.2026 MISL.LN IE000NVDQXE1 4,150,002.00 USD 140,281,239.08 33.803  ...

AMSTERDAM--(BUSINESS WIRE)--Nebius Group N.V. (NASDAQ: NBIS), the AI cloud company, today announced its unaudited financial results for the first quarter ended March 31, 2026. Nebius today also announced that it has secured up to 1.2 GW of power and land for a new, owned AI factory at a site in Pennsylvania. The Company today also published founder and CEO Arkady Volozh’s quarterly letter to shareholders, available on its investor relations website at https://nebius.com/investor-hub (PDF). Mana...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported financial results for the quarter ended March 31, 2026, and highlighted recent progress across its pipeline of clinical-stage product candidates. “2026 is off to a strong start across our pipeline, highlighted by the initiation of the Phase 2b trial of ALTO-207 in T...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 12.05.2026 QSEP.LN IE000FQ808R5 450,002.00 USD 10,921,750.56 24.270  ...

BOSTON--(BUSINESS WIRE)--Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE:TDY), announced that its Rogue™ 1 loitering munition system has been selected by the U.S. Army for its Low Altitude Stalking and Strike Ordnance (LASSO) program. Teledyne FLIR will deliver a variant of its Rogue 1 lethal UAS for LASSO. Launched in spring 2024, the U.S.-designed and built Rogue 1 already has been delivered to both U.S. Special Operations Command (Ground Organic Precision Strike Syste...

SAN FRANCISCO--(BUSINESS WIRE)--Carta, the agentic enterprise resource planning (ERP) platform for private capital, today announced it has acquired Avantia, a leading AI-powered legal and compliance law firm for asset managers. The acquisition launches Carta Law—the largest AI-native, integrated legal and compliance solution for private markets—unifying legal and compliance workflows with fund operations on a single platform. Private capital firms have long operated with fragmented infrastructu...

MP MENASHE, Israel--(BUSINESS WIRE)--Caesarstone Ltd. (NASDAQ: CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today reported financial results for its first quarter ended March 31, 2026. Yos Shiran, Caesarstone’s Chief Executive Officer commented, “First quarter results reflect meaningful structural progress in our ongoing transformation. Gross margin expanded driven by the increasing contribution of our transition to a third-party manufacturing model despite c...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Liberate Bio, Inc., a biotechnology company developing genetic medicines that deliver RNA therapies directly to immune cells, today announced new pre-clinical data supporting LIB820, the company’s lead in vivo CAR-M program for autoimmune disease. LIB820 is Liberate’s first-in-human (FIH) study and is currently on track for initiation at the end of 2026. The data will be presented at the American Society of Gene and Cell Therapies conference in Boston by Dr. W...

DALLAS--(BUSINESS WIRE)--Buda Juice, Inc. (NYSE American: BUDA), $BUDA, creator and pioneer of the Ultra Fresh™ category in the supermarket fresh perimeter, today reported financial results for the quarter ended March 31, 2026. Horatio Lonsdale-Hands, Co-Founder and Chief Executive Officer of Buda Juice, commented: "The first quarter of fiscal 2026 represents a meaningful milestone for Buda Juice. It was effectively our first full quarter as a public company, and we delivered on our commitments...